Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide - A pilot study
We examined the effects of liraglutide, a glucagon-like peptide-1 analogue on appetite and plasma ghrelin in non-diabetic obese participants with subclinical binge eating (BE). Forty-four obese BE participants (mean age: 34 ± 9 years, BMI: 35.9 ± 4.2 kg/m2) were randomly assigned to intervention or...
| الحاوية / القاعدة: | Obesity Research and Clinical Practice |
|---|---|
| المؤلف الرئيسي: | |
| التنسيق: | Letter |
| اللغة: | English |
| منشور في: |
Elsevier Ltd
2015
|
| الوصول للمادة أونلاين: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930868992&doi=10.1016%2fj.orcp.2015.03.005&partnerID=40&md5=857369c0ee9b56aed1f123e7a4d13b15 |